Physician profile

David C Lew

Cardiovascular Disease · Leesburg, FL

NPI 1861485757

$90,215.32

in general payments reported to CMS, 2019-2025

39 companies · $19K in 2025

The $19K reported for 2025 was more than what 96% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Long Term Medical Supply Or Device Loan$78,416.68
Food and Beverage$4,523.82
Travel and Lodging$255.17

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Angiodynamics, INC. $78,943.04 2022-2025 Auryon Laser System 100-120 Vac, Auryon Laser System 100-120 Vac
Boston Scientific Corporation $2,217.38 2019-2025 Watchman Flx, Eluvia, Mustang
W. L. Gore & Associates, INC. $1,771.36 2019-2025 Gore Viabahn Vbx Balloon Expandable Endo, Gore Viabahn Endoprosthesis With Heparin
Penumbra, INC. $1,733.21 2019-2025 Indigo System, Penumbra System
Medtronic, INC. $1,622.29 2021-2025 Resolute Onyx, Symplicity G3, Onyx Frontier
Cardinal Health 200 LLC $502.07 2019-2020
Abbott Laboratories $457.79 2020-2025 Triclip
Abiomed $378.09 2019-2024 Impella
Medtronic Vascular, INC. $348.56 2019-2020
Cordis US Corp. $225.71 2021-2024 Mynxgrip, Brite Tip Radianz, Raiden3t
Philips North America LLC $217.58 2019-2025 Extended Holter
Edwards Lifesciences Corporation $216.32 2021-2025 Pascal
Pfizer INC. $202.78 2019-2025
Tosoh Bioscience, INC. $169.00 2019
Inari Medical, INC. $154.35 2024 Flowtriever Catheter, S, Ct Thrombectomy System Kit
Show all 39 companies
CompanyGeneral paymentsYearsTop products
Canon Medical Systems USA, INC. $148.08 2019-2020
Merck Sharp & Dohme LLC $116.43 2023-2025 Verquvo, Capvaxive
Esperion Therapeutics, INC. $109.05 2021-2023 Nexletol
Cvrx, INC. $103.04 2024 Barostim Neo System
Biosense Webster, INC. $102.64 2023-2025 Na, Nuvision Ice Catheter
Sanofi-Aventis U.S. LLC $68.05 2019-2020
Reflow Medical INC $52.66 2024
Amgen INC. $50.32 2019-2024 Repatha
Astrazeneca Pharmaceuticals LP $41.74 2020-2022
Teleflex LLC $39.05 2019-2020
Heartflow, INC. $27.39 2025
Cardiovascular Systems INC. $23.51 2023 Diamondback Peripheral
Lexicon Pharmaceuticals, INC. $20.10 2023 Inpefa
Biotronik INC. $18.82 2022
Contego Medical, INC $16.83 2025
Janssen Pharmaceuticals, INC $15.45 2023 Xarelto
Scpharmaceuticals INC. $14.62 2023
Welch Allyn $14.08 2021
E.R. Squibb & Sons, L.L.C. $14.01 2024 Camzyos
Novartis Pharmaceuticals Corporation $13.27 2024
Amarin Pharma, INC. $12.87 2020
Zoll Services LLC (A/K/A Zoll Lifecor Corp) $11.77 2023 Lifevest
Ge Healthcare $11.15 2020
Arbor Pharmaceuticals, INC. $10.86 2019

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

David C Lew

$90,215.32

in general payments reported 2019-2025

Years
2019-2025
Top company
Angiodynamics, INC.
Context
The $19K reported for 2025 was more than what 96% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).

https://glasscript.com/doctor/357296/david-c-lew

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.